Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence
Read More Healthcare Industry News VisCardia wraps up VisONE heart failure pilot study VisONE heart failure pilot study : Oregon-based medical device developer VisCardia has wrapped up its first-in-human study of… bypharmanewsdailyMarch 10, 2020
